English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessStocksSell Sun Pharma: Shrikant Chauhan

    Sell Sun Pharma: Shrikant Chauhan

    Shrikant Chauhan of Kotak Securities feels that one should sell Sun Pharma.

    May 04, 2012 / 12:27 IST
     
     
    live
    • bselive
    • nselive
    Volume
    Todays L/H
    More

    Shrikant Chauhan of Kotak Securities feels that one should sell Sun Pharma.


    Chauhan told CNBC-Awaaz, "One can sell Sun Pharma with one month view. The stoploss should keep at Rs 600. We can see level of Rs 560 at down side."


    The company's trailing 12-month (TTM) EPS was at Rs 13.36 per share. (Dec, 2011). The stock's price-to-earnings (P/E) ratio was 44.90. The latest book value of the company is Rs 64.51 per share. At current value, the price-to-book value of the company was 9.3. The dividend yield of the company was 0.58%.

    first published: Apr 27, 2012 04:13 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347